AI Article Synopsis

  • The primary goal of osteoporosis management is to prevent fractures through individualized, goal-directed treatment plans.
  • Effective treatment requires assessing a patient's fracture history, bone mineral density (BMD), and other major risk factors to determine the best course of action.
  • Initial treatment should prioritize rapid fracture risk reduction for high-risk patients and take into account the likelihood of meeting BMD targets with either osteoanabolic or antiresorptive therapies.

Article Abstract

The overarching goal of osteoporosis management is to prevent fractures. A goal-directed approach to long-term management of fracture risk helps ensure that the most appropriate initial treatment and treatment sequence is selected for individual patients. Goal-directed treatment decisions require assessment of clinical fracture history, vertebral fracture identification (using vertebral imaging as appropriate), measurement of bone mineral density (BMD), and consideration of other major clinical risk factors. Treatment targets should be tailored to each patient's individual risk profile and based on the specific indication for beginning treatment, including recency, site, number and severity of prior fractures, and BMD levels at the total hip, femoral neck, and lumbar spine. Instead of first-line bisphosphonate treatment for all patients, selection of initial treatment should focus on reducing fracture risk rapidly for patients at very high and imminent risk, such as in those with recent fractures. Initial treatment selection should also consider the probability that a BMD treatment target can be attained within a reasonable period of time and the differential magnitude of fracture risk reduction and BMD impact with osteoanabolic versus antiresorptive therapy. This position statement of the ASBMR/BHOF Task Force on Goal-Directed Osteoporosis Treatment provides an overall summary of the major clinical recommendations about treatment targets and strategies to achieve those targets based on the best evidence available, derived primarily from studies in older postmenopausal women of European ancestry.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11425703PMC
http://dx.doi.org/10.1093/jbmr/zjae119DOI Listing

Publication Analysis

Top Keywords

treatment
12
fracture risk
12
initial treatment
12
goal-directed osteoporosis
8
osteoporosis treatment
8
asbmr/bhof task
8
task force
8
position statement
8
major clinical
8
treatment targets
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!